Paratek Pharmaceuticals
Paratek Pharmaceuticals (NASDAQ: PRTK) is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments. We focus on drugs that target infectious disease and other difficult to treat conditions. Our lead product candidate, omadacycline, is the first in a new class of tetracyclines known as aminomethycyclines, with broad spectrum activity against Gram-positive, Gram-negative and atypical bacteria. Omadacycline is being developed as a once daily, oral and intravenous, empiric monotherapy for community acquired bacterial infections, particularly when antibiotic resistance is of concern. The Food and Drug Administration (FDA) granted omadacycline a Qualified Infectious Disease Product (QIDP) designation and completed two special protocol assessments for its Phase 3 clinical trial program.
Pharmaceuticals
50 - 200
Boston, MA, United States
About

Paratek Pharmaceuticals (NASDAQ: PRTK) is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments. We focus on drugs that target infectious disease and other difficult to treat conditions.

Our lead product candidate, omadacycline, is the first in a new class of tetracyclines known as aminomethycyclines, with broad spectrum activity against Gram-positive, Gram-negative and atypical bacteria. Omadacycline is being developed as a once daily, oral and intravenous, empiric monotherapy for community acquired bacterial infections, particularly when antibiotic resistance is of concern. The Food and Drug Administration (FDA) granted omadacycline a Qualified Infectious Disease Product (QIDP) designation and completed two special protocol assessments for its Phase 3 clinical trial program.

Site Traffic
  • 4760959 Global Rank
  • 1155674
    United States
Traffic Sources
  • Search
    55.24%
  • Direct
    42.03%
  • Referrals
    2.73%
  • Display
    0.00%
  • Mail
    0.00%
  • Social
    0.00%
Powered by
Alexa Traffic Data
Global Rank 833,506
6,581,666
United States Rank 198,944
18,195
United States Page Views 97.2%
2.1%
Top Countries
Top Search Keywords
  • Irving
Paratek Pharmaceuticals receives up to 0.02M pageviews per day.

They are headquartered at Boston, MA, United States, and have 2 advertising & marketing contacts listed on Kochava. Paratek Pharmaceuticals works with Advertising technology companies such as DoubleClick.Net.